definiens: as that term is defined in the Private Securities LitigationReform Act of 1995, regarding the research, development and commercialization of pharmaceutical products . Suchforward - looking statements are based on current expectations and involve inherent risks and uncertainties, includingfactors that could delay, divert or change any of them, and could cause actual outcomes and results to differmaterially from current expectations . No forward - looking statement can be guaranteed . Among other risks, there canbe no guarantee that the clinical trials described in this release will support a regulatory filing or that the productsdescribed in this release will receive regulatory approval . There can be no assurance that if approved, the productswill be commercially successful . Forward - looking statements in the press release should be evaluated together withthe many uncertainties that affect Bristol - Myers Squibb ’s business, particularly those identified in the cautionaryfactors discussion in Bristol - Myers Squibb ’s Annual Report on Form 10 - K for the year ended December 31, 2007, itsQuarterly Reports on Form 10 - Q, and Current Reports on Form 8 - K. Bristol - Myers Squibb undertakes no obligation topublicly update any forward - looking statement, whether as a result of new information, future events, or otherwise